Drug-induced lupus erythematosus
ORPHA:231111DiseaseNot applicableAll ages
Фенотипы (HPO)23
Очень частый (80–99%)20
HP:0000790Hematuria
HP:0000967Petechiae
HP:0001698Pericardial effusion
HP:0001701Pericarditis
HP:0001873Thrombocytopenia
HP:0001903Anemia
HP:0002094Dyspnea
HP:0002829Arthralgia
HP:0003138Increased blood urea nitrogen
HP:0003236Elevated circulating creatine kinase concentration
HP:0003326Myalgia
HP:0003493Antinuclear antibody positivity
HP:0003565Elevated erythrocyte sedimentation rate
HP:0005184Prolonged QTc interval
HP:0005421Decreased circulating complement C3 concentration
HP:0011227Elevated circulating C-reactive protein concentration
HP:0025300Malar rash
HP:0025343Lupus anticoagulant
HP:0030057Autoimmune antibody positivity
HP:0045042Decreased circulating complement C4 concentration
Частый (30–79%)2
HP:0001945Fever
HP:0045073Serositis
Периодический (5–29%)1
HP:0025142Constitutional symptom
Эпидемиология1
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Point prevalence | Unknown | — | Worldwide | Class only |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)